Echinops telfairi (small Madagascar hedgehog): 101648971
Help
Entry
101648971 CDS
T08707
Symbol
MAPK3
Name
(RefSeq) mitogen-activated protein kinase 3
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
etf
Echinops telfairi (small Madagascar hedgehog)
Pathway
etf01521
EGFR tyrosine kinase inhibitor resistance
etf01522
Endocrine resistance
etf01524
Platinum drug resistance
etf04010
MAPK signaling pathway
etf04012
ErbB signaling pathway
etf04014
Ras signaling pathway
etf04015
Rap1 signaling pathway
etf04022
cGMP-PKG signaling pathway
etf04024
cAMP signaling pathway
etf04062
Chemokine signaling pathway
etf04066
HIF-1 signaling pathway
etf04068
FoxO signaling pathway
etf04071
Sphingolipid signaling pathway
etf04072
Phospholipase D signaling pathway
etf04114
Oocyte meiosis
etf04140
Autophagy - animal
etf04148
Efferocytosis
etf04150
mTOR signaling pathway
etf04151
PI3K-Akt signaling pathway
etf04210
Apoptosis
etf04218
Cellular senescence
etf04261
Adrenergic signaling in cardiomyocytes
etf04270
Vascular smooth muscle contraction
etf04350
TGF-beta signaling pathway
etf04360
Axon guidance
etf04370
VEGF signaling pathway
etf04371
Apelin signaling pathway
etf04380
Osteoclast differentiation
etf04510
Focal adhesion
etf04520
Adherens junction
etf04540
Gap junction
etf04550
Signaling pathways regulating pluripotency of stem cells
etf04611
Platelet activation
etf04613
Neutrophil extracellular trap formation
etf04620
Toll-like receptor signaling pathway
etf04621
NOD-like receptor signaling pathway
etf04625
C-type lectin receptor signaling pathway
etf04650
Natural killer cell mediated cytotoxicity
etf04657
IL-17 signaling pathway
etf04658
Th1 and Th2 cell differentiation
etf04659
Th17 cell differentiation
etf04660
T cell receptor signaling pathway
etf04662
B cell receptor signaling pathway
etf04664
Fc epsilon RI signaling pathway
etf04666
Fc gamma R-mediated phagocytosis
etf04668
TNF signaling pathway
etf04713
Circadian entrainment
etf04720
Long-term potentiation
etf04722
Neurotrophin signaling pathway
etf04723
Retrograde endocannabinoid signaling
etf04724
Glutamatergic synapse
etf04725
Cholinergic synapse
etf04726
Serotonergic synapse
etf04730
Long-term depression
etf04810
Regulation of actin cytoskeleton
etf04910
Insulin signaling pathway
etf04912
GnRH signaling pathway
etf04914
Progesterone-mediated oocyte maturation
etf04915
Estrogen signaling pathway
etf04916
Melanogenesis
etf04917
Prolactin signaling pathway
etf04919
Thyroid hormone signaling pathway
etf04921
Oxytocin signaling pathway
etf04926
Relaxin signaling pathway
etf04928
Parathyroid hormone synthesis, secretion and action
etf04929
GnRH secretion
etf04930
Type II diabetes mellitus
etf04933
AGE-RAGE signaling pathway in diabetic complications
etf04934
Cushing syndrome
etf04935
Growth hormone synthesis, secretion and action
etf04960
Aldosterone-regulated sodium reabsorption
etf05010
Alzheimer disease
etf05020
Prion disease
etf05022
Pathways of neurodegeneration - multiple diseases
etf05034
Alcoholism
etf05132
Salmonella infection
etf05133
Pertussis
etf05135
Yersinia infection
etf05140
Leishmaniasis
etf05142
Chagas disease
etf05145
Toxoplasmosis
etf05152
Tuberculosis
etf05160
Hepatitis C
etf05161
Hepatitis B
etf05163
Human cytomegalovirus infection
etf05164
Influenza A
etf05165
Human papillomavirus infection
etf05166
Human T-cell leukemia virus 1 infection
etf05167
Kaposi sarcoma-associated herpesvirus infection
etf05170
Human immunodeficiency virus 1 infection
etf05171
Coronavirus disease - COVID-19
etf05200
Pathways in cancer
etf05203
Viral carcinogenesis
etf05205
Proteoglycans in cancer
etf05206
MicroRNAs in cancer
etf05207
Chemical carcinogenesis - receptor activation
etf05208
Chemical carcinogenesis - reactive oxygen species
etf05210
Colorectal cancer
etf05211
Renal cell carcinoma
etf05212
Pancreatic cancer
etf05213
Endometrial cancer
etf05214
Glioma
etf05215
Prostate cancer
etf05216
Thyroid cancer
etf05218
Melanoma
etf05219
Bladder cancer
etf05220
Chronic myeloid leukemia
etf05221
Acute myeloid leukemia
etf05223
Non-small cell lung cancer
etf05224
Breast cancer
etf05225
Hepatocellular carcinoma
etf05226
Gastric cancer
etf05230
Central carbon metabolism in cancer
etf05231
Choline metabolism in cancer
etf05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
etf05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
etf00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101648971 (MAPK3)
04012 ErbB signaling pathway
101648971 (MAPK3)
04014 Ras signaling pathway
101648971 (MAPK3)
04015 Rap1 signaling pathway
101648971 (MAPK3)
04350 TGF-beta signaling pathway
101648971 (MAPK3)
04370 VEGF signaling pathway
101648971 (MAPK3)
04371 Apelin signaling pathway
101648971 (MAPK3)
04668 TNF signaling pathway
101648971 (MAPK3)
04066 HIF-1 signaling pathway
101648971 (MAPK3)
04068 FoxO signaling pathway
101648971 (MAPK3)
04072 Phospholipase D signaling pathway
101648971 (MAPK3)
04071 Sphingolipid signaling pathway
101648971 (MAPK3)
04024 cAMP signaling pathway
101648971 (MAPK3)
04022 cGMP-PKG signaling pathway
101648971 (MAPK3)
04151 PI3K-Akt signaling pathway
101648971 (MAPK3)
04150 mTOR signaling pathway
101648971 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
101648971 (MAPK3)
04148 Efferocytosis
101648971 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
101648971 (MAPK3)
04210 Apoptosis
101648971 (MAPK3)
04218 Cellular senescence
101648971 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
101648971 (MAPK3)
04520 Adherens junction
101648971 (MAPK3)
04540 Gap junction
101648971 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
101648971 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
101648971 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
101648971 (MAPK3)
04613 Neutrophil extracellular trap formation
101648971 (MAPK3)
04620 Toll-like receptor signaling pathway
101648971 (MAPK3)
04621 NOD-like receptor signaling pathway
101648971 (MAPK3)
04625 C-type lectin receptor signaling pathway
101648971 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
101648971 (MAPK3)
04660 T cell receptor signaling pathway
101648971 (MAPK3)
04658 Th1 and Th2 cell differentiation
101648971 (MAPK3)
04659 Th17 cell differentiation
101648971 (MAPK3)
04657 IL-17 signaling pathway
101648971 (MAPK3)
04662 B cell receptor signaling pathway
101648971 (MAPK3)
04664 Fc epsilon RI signaling pathway
101648971 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
101648971 (MAPK3)
04062 Chemokine signaling pathway
101648971 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
101648971 (MAPK3)
04929 GnRH secretion
101648971 (MAPK3)
04912 GnRH signaling pathway
101648971 (MAPK3)
04915 Estrogen signaling pathway
101648971 (MAPK3)
04914 Progesterone-mediated oocyte maturation
101648971 (MAPK3)
04917 Prolactin signaling pathway
101648971 (MAPK3)
04921 Oxytocin signaling pathway
101648971 (MAPK3)
04926 Relaxin signaling pathway
101648971 (MAPK3)
04935 Growth hormone synthesis, secretion and action
101648971 (MAPK3)
04919 Thyroid hormone signaling pathway
101648971 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
101648971 (MAPK3)
04916 Melanogenesis
101648971 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
101648971 (MAPK3)
04270 Vascular smooth muscle contraction
101648971 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
101648971 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
101648971 (MAPK3)
04725 Cholinergic synapse
101648971 (MAPK3)
04726 Serotonergic synapse
101648971 (MAPK3)
04720 Long-term potentiation
101648971 (MAPK3)
04730 Long-term depression
101648971 (MAPK3)
04723 Retrograde endocannabinoid signaling
101648971 (MAPK3)
04722 Neurotrophin signaling pathway
101648971 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
101648971 (MAPK3)
04380 Osteoclast differentiation
101648971 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
101648971 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
101648971 (MAPK3)
05206 MicroRNAs in cancer
101648971 (MAPK3)
05205 Proteoglycans in cancer
101648971 (MAPK3)
05207 Chemical carcinogenesis - receptor activation
101648971 (MAPK3)
05208 Chemical carcinogenesis - reactive oxygen species
101648971 (MAPK3)
05203 Viral carcinogenesis
101648971 (MAPK3)
05230 Central carbon metabolism in cancer
101648971 (MAPK3)
05231 Choline metabolism in cancer
101648971 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
101648971 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
101648971 (MAPK3)
05212 Pancreatic cancer
101648971 (MAPK3)
05225 Hepatocellular carcinoma
101648971 (MAPK3)
05226 Gastric cancer
101648971 (MAPK3)
05214 Glioma
101648971 (MAPK3)
05216 Thyroid cancer
101648971 (MAPK3)
05221 Acute myeloid leukemia
101648971 (MAPK3)
05220 Chronic myeloid leukemia
101648971 (MAPK3)
05218 Melanoma
101648971 (MAPK3)
05211 Renal cell carcinoma
101648971 (MAPK3)
05219 Bladder cancer
101648971 (MAPK3)
05215 Prostate cancer
101648971 (MAPK3)
05213 Endometrial cancer
101648971 (MAPK3)
05224 Breast cancer
101648971 (MAPK3)
05223 Non-small cell lung cancer
101648971 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
101648971 (MAPK3)
05170 Human immunodeficiency virus 1 infection
101648971 (MAPK3)
05161 Hepatitis B
101648971 (MAPK3)
05160 Hepatitis C
101648971 (MAPK3)
05171 Coronavirus disease - COVID-19
101648971 (MAPK3)
05164 Influenza A
101648971 (MAPK3)
05163 Human cytomegalovirus infection
101648971 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
101648971 (MAPK3)
05165 Human papillomavirus infection
101648971 (MAPK3)
09171 Infectious disease: bacterial
05132 Salmonella infection
101648971 (MAPK3)
05135 Yersinia infection
101648971 (MAPK3)
05133 Pertussis
101648971 (MAPK3)
05152 Tuberculosis
101648971 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
101648971 (MAPK3)
05140 Leishmaniasis
101648971 (MAPK3)
05142 Chagas disease
101648971 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
101648971 (MAPK3)
05020 Prion disease
101648971 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
101648971 (MAPK3)
09165 Substance dependence
05034 Alcoholism
101648971 (MAPK3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101648971 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
101648971 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
101648971 (MAPK3)
04934 Cushing syndrome
101648971 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
101648971 (MAPK3)
01524 Platinum drug resistance
101648971 (MAPK3)
01522 Endocrine resistance
101648971 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
etf01001
]
101648971 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
etf03036
]
101648971 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
etf04147
]
101648971 (MAPK3)
Enzymes [BR:
etf01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
101648971 (MAPK3)
Protein kinases [BR:
etf01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
101648971 (MAPK3)
Chromosome and associated proteins [BR:
etf03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
101648971 (MAPK3)
Exosome [BR:
etf04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
101648971 (MAPK3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
APH
ABC1
Haspin_kinase
FTA2
Kdo
Motif
Other DBs
NCBI-GeneID:
101648971
NCBI-ProteinID:
XP_004705746
LinkDB
All DBs
Position
Unknown
AA seq
452 aa
AA seq
DB search
MARLCLLLPPQVAQCTHRPLQAAHPLPPGPQPYLLPEMTMSLRVEDEEVEEEAPRLGLHP
GSLVVALRPEIYTSQEQADLLASAAAQLQRCQPSPAPSPLCQALGGAASPGLPPGKATHR
PCQQLSGPFSSAYDQVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL
RAPTLEGMRDVYIVQDLMETDLYKLLKSQHLSNDHICYFLYQILRGLKYIHSANVLHRDL
KPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID
IWSVGCILAEMLSNRPIFPGKHYLDQLNHILSILGSPSQEDLNCIINMKARNYLQSLPAK
TKVAWAKLFPKADPKALELLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFT
FDMELDDLPKERLKELIFQETARFQPGAAEVP
NT seq
1359 nt
NT seq
+upstream
nt +downstream
nt
atggcccggctctgcctcctcctccccccgcaggtggcccagtgcacgcacaggcctctg
caggcagcccaccccctccccccaggtccccagccctacctgctgccagagatgacaatg
agcctccgagtggaggacgaagaagtggaggaggaggcgccccggctgggcctgcaccca
gggagcctggttgtcgccctgcgccccgaaatttacacaagccaggagcaggccgatctc
ctggcttcagcagccgcccagcttcaaaggtgccagccctctcctgctccctcccctctc
tgccaagccctgggtggggccgccagccctggactcccccctggtaaggccacacaccgt
ccatgtcaacagctctctggccctttcagctctgcctacgaccaagtgcgcaagactcgg
gtggccatcaagaagatcagccccttcgagcaccagacctactgccagcgcacgctgcgt
gagatccagatcttgctgcgcttccgccacgagaatgtcatcggcatccgagacattctg
cgggcacccaccctggaaggcatgagggatgtctacatcgtgcaggacctgatggagacc
gacctgtataagttgcttaagagccagcacctcagcaatgaccacatctgctacttcctc
taccagatcctgcggggcctcaagtacatccactcggccaacgtgctccaccgcgacctg
aagccctccaacctgctcatcaacaccacctgtgaccttaagatttgtgattttggcctg
gcccgcatcgccgaccctgagcacgaccacacgggcttcttgacagagtatgtggccacc
cgctggtaccgagcaccagagatcatgctcaactccaagggctacaccaaatccatcgac
atctggtctgtgggctgcatcctggctgagatgctctccaaccggcctatcttcccgggc
aagcactacctggaccagctgaaccacattctgagtattctgggctccccgtcccaggag
gacctgaattgtatcatcaacatgaaggcccggaattacctgcagtctttgccagccaag
accaaggttgcctgggccaagctttttcccaaggcagaccccaaagcccttgaactgctg
gatcggatgttgacctttaaccccaacaaacggatcacagtggaggaagcgttggcccac
ccctacctggagcagtactatgaccccacggatgagcccgtggctgaggagcccttcacc
ttcgacatggagctggatgacctccccaaggagcggctgaaggagctcattttccaagag
accgcacgcttccagcctggggccgcagaggtcccctag
DBGET
integrated database retrieval system